HopeStage
Back to all studies
CompletedNCT05259943

Testing psychedelic microdosing for mood in depression

About this titleRead the official source — NCT05259943
Medication studyAges 18–65Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
TorontoSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 15, 2023
Recruitment status
Completed
Enrollment listed in the registry
39
Sponsor
Rotem Petranker
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT05259943
Official title
Show the full official title

Microdosing Psychedelics to Improve Mood

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Rotem Petranker.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin first and Placebo first.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies